Biodegradable polymer films for releasing nanovehicles containing sirolimus Biodegradable polymer containing nanovehicles with sirolimus Hyung Il Kim et al.

Drug Delivery

Volumn 16, Issue 4, 2009, Pages 183-188

  Kim, Hyung Il ^a,b   Takai, Madoka ^b   Konno, Tomohiro ^b   Matsuno, Ryosuke ^b   Ishihara, Kazuhiko ^a,b  

^a School of Engineering   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

2 methacryloyloxyethyl phosphorylcholine polymer; Biodegradable polymer film; Drug eluting stents; Nanovehicles; Sirolimus

Indexed keywords

NANOCARRIER; PHOSPHATE BUFFERED SALINE; POLY(2 METHACRYLOYLOXYETHYLPHOSPHORYLCHOLINE RANDOM N BUTYLMETHYLCRYLATE; POLY(LACTIDE RANDOM CAPROLACTONE RANDOM GLYCOLIDE); POLYMER; RAPAMYCIN; UNCLASSIFIED DRUG; DRUG CARRIER; NANOPARTICLE; WATER;

ARTICLE; BIODEGRADABILITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FILM; HYDRODYNAMICS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; CHEMISTRY; DRUG ELUTING STENT;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; POLYMERS; SIROLIMUS; WATER;

EID: 70350662680     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540902757416     Document Type: Article

References (22)

1. Mauri L, Hsieh W, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. (2007). Stent thrombosis in randomized clinical trials of drugeluting stents. N Engl J Med, 356, 1020-1029
2. Kukreja N, Onuma Y, Daemen J, Serruys PW. (2008). The future of drug-eluting stents. Pharmacol Res, 57, 171-180
3. Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. (2008). A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet, 371, 899-907.
4. Kim HI, Takai M, Ishihara K. (2009). The bioabsorbable materials containing phosphorylcholine group-rich surfaces for temporary scaffolding of the vessel wall. Tissue Eng, doi: 10.1089/ ten.tea.2008.0307.
5. Dzau VJ, Braun-Dullaes RC, Sedding DG. (2002). Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med, 8, 1249-1256
6. Rainer W, Blaich B, BelAiba RS, Merl S, Görlach A, Kastrati A. (2007). Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Thromb Haemost, 97, 1003-1012
7. Serruys PW, Kutryk MJB, Ong ATL. (2006). Coronary-artery stents. N Engl J Med, 354, 483-495
8. Wang X, Venkatraman SS, Boey FYC, Loo JSC, Tan LP. (2006). Controlled release of sirolimus from a multilayered PLGA stent matrix. Biomaterials, 27, 5588-5595
9. Alexis F, Venkatraman SS, Rath SK, Boey F. (2004). In vitro study of release mechanisms of paclitaxel and rapamycin from drugincorporated biodegradable stent matrices. J Contr Rel, 98, 67-74.
10. Ferron GM, Jusko WJ. (1998). Species differences in sirolimus stability in humans, rabbits, and rats. Drug Metab Dispos, 26, 83-84
11. Trepanier DJ, Gallant H, Legatt DF, Yatscoff RW. (1998). Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update. Clin Biochem, 31, 1345-1351
12. Duncan R. (2003). The dawning era of polymer therapeutics. Nat Rev Drug Discov, 2, 347-360
13. Diab C, Tribet C, Gohon Y, Popot J-L, Winnik FM. (2007). Complexation of integral membrane proteins by phosphorylcholine-based amphipols. Biochim Biophys Acta, 1768, 2737-2747
14. Gohon Y, Giusti F, Prata C, Charvolin D, Timmins P, Ebel C, Tribet C, Popot J -L. (2006). Well-defined nanoparticles formed by hydrophobic assembly of a short and polydisperse random terpolymer, amphipol A8-35. Langmuir, 22, 1281-1290
15. Ishihara K, Iwasaki Y, Nakabayashi N. (1999). Polymeric lipid nanosphere consisting of water-soluble poly(2-methacryloyloxyethyl phosphorylcholine-co-n- butyl methacrylate). Polym J, 31, 1231-1236
16. Konno T, Watanabe J, Ishihara K. (2003). Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phophorylcholine polymers. J Biomed Mater Res,65A, 210-215
17. Wada M, Jinno H, Ueda M, Ikeda T, Kitajima M, Konno T, Watanabe J, Ishihara K. (2007). Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxiel. Anticancer Res, 27, 1431-1436
18. Pires NMM, Van Der Hoeven BL, De Vries MR, Havekes LM, Van Vlijmen BJ, Hennink WE, Quax PHA, Jukema JW. (2005). Local perivascular delivery of anti-restenotic agents from a drug- eluting poly(å-caprolactone) stent cuff. Biomaterials, 26, 5386-5394
19. Ricciutelli M, Martino PD, Barboni L, Martelli S. (2006). Evaluation of rapamycin chemical stability in volatile-organic solvents by HPLC. J Pharm Biomed, 41, 1070-1074
20. Diab C, Winnik FM, Tribet C. (2007). Enthalpy of interaction and binding isotherms of non-ionic surfactants onto micellar amphiphilic polymers (amphipols). Langmuir, 23, 3025-3035
21. Tada S, Tarbell JM. (2004). Internal elastic lamina affects the distribution of macromolecules in the arterial wall: a computational study. Am J Physiol Heart Circ Physiol, 287, 905-913
22. Balakrishnan B, Dooley J, Kopia G, Edelman ER. (2008). Thrombus causes fluctuations in arterial drug delivery from intravascular stents. J Contr Rel. 131, 173-180.